Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 9 Sep 2026 UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA[®] (certolizumab pegol) in... Read More Press release 8 Sep 2026 UCB opens ‘Expressing Epilepsy’ art exhibition featuring acclaimed artists living with epilepsy Read More Press release 1 Sep 2026 UCB presents data at EEC 2026 highlighting continued leadership in epilepsy and developmental and... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 9 Sep 2026 UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA[®] (certolizumab pegol) in... Read More
Press release 8 Sep 2026 UCB opens ‘Expressing Epilepsy’ art exhibition featuring acclaimed artists living with epilepsy Read More
Press release 1 Sep 2026 UCB presents data at EEC 2026 highlighting continued leadership in epilepsy and developmental and... Read More
